• FDA Computational and Experimental Assessment of Engineered Biotherapeutics: Safety and Regulatory Considerations of Synonymous Gene Recoding

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 3 days ago
    • May 22, 2026
  • FDA Prophylactic Vaccine Against Visceral Leishmaniasis Post-doctoral Fellowship

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 3 days ago
    • May 22, 2026
  • FDA Optimization Modeling to Support Benefit-Risk Assessment Fellowship

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 3 days ago
    • May 22, 2026
  • FDA Non-clinical Identification and Mitigation of Safety Risks During the Development and Licensure of Protein-therapeutics

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 3 days ago
    • May 22, 2026
  • FDA CDER Regulatory Science Fellowship

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 4 days ago
  • FDA In Vitro and In Vivo Bioequivalence Fellowship

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 4 days ago
    • March 30, 2026
  • FDA Postdoctoral Fellowship / Research Fellowship: Enhancing the Review of Mediation Analyses—Developing a Regulatory Checklist and AI Support Tool

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 4 days ago
    • May 22, 2026
  • FDA Pharmacy Compounding Regulatory Analysis Fellowship

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 4 days ago
    • May 22, 2026
  • FDA Evaluation and Characterization of Neutralizing Antibodies Against Viruses Relevant to Blood-Derived Products

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 4 days ago
    • May 8, 2026
  • FDA Application of Quantitative Approaches to Streamline Drug Development and Enhance Patient Care

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 4 days ago
    • May 31, 2026
  • FDA Advanced Evaluation of Postmarket Product Quality Reports

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 4 days ago
    • May 31, 2026
  • FDA Fellowship – Optimization of Drug-induced Liver Injury Analysis Methods

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 4 days ago
    • May 29, 2026
  • FDA Research Opportunity – Analysis of Patient Diversity and Ineligibility Rates in Cancer Pivotal Clinical Trials

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 4 days ago
    • May 29, 2026
  • FDA Fellowship – Large language Models in Post-Market Surveillance of Drugs Using Social Media

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 4 days ago
    • May 29, 2026
  • FDA Application of AI for Precision Medicine Fellowship

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 6 days ago
  • FDA Development of Cell-based Reporter Assays for FSH, LH and hCG

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 6 days ago
  • FDA Quality Knowledge Management Throughout the Drug Product Lifecycle

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 1 week ago
    • May 31, 2026
  • FDA Development of Analytical Methods to Assess Nitrosamine Impurities in Over-the-Counter (OTC) Monograph Drug Products

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 1 week ago
    • June 12, 2026
  • FDA Biomarker Qualification Fellowship

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 1 week ago
    • April 15, 2026
  • FDA Utilizing Artificial Intelligence to Enhance Pharmacovigilance and Inspection Fellowship

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 1 week ago
    • May 31, 2026
  • FDA Nonclinical Data and Drug Safety Regulatory Research Fellowship

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 1 week ago
    • May 31, 2026
  • FDA Regulatory Science Research Project Related to Safety of Medications in Pregnancy in the Post Approval Setting

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 1 week ago
    • May 31, 2026
  • Comparing Neonatal Adverse Drug Events from the Literature with FDA Labels

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 1 week ago
    • May 31, 2026
  • FDA Development of a Cell-based Potency Assay for Reproductive Hormone Therapies

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 1 week ago
    • May 31, 2026
  • FDA Studying the Critical Quality Attributes of Multispecific Antibodies/Fusion Proteins (SARITA 4400)

    U.S. Food and Drug Administration (FDA)
    • Fellowship
    • Posted 1 week ago
    • May 31, 2026